Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.

Maria Giuseppa VitaleSarah ScagliariniLuca GalliSandro PignataGiovanni Lo ReAlfredo BerrutiCarlotta DefferrariMassimiliano SpadaCristina MasiniDaniele SantiniLibero CiuffredaEnzo Maria RuggeriCarmelo BengalaLorenzo LiviDaniele FagnaniAndrea BonettiLucio GiustiniAlketa HamzajGiuseppe ProcopioClaudia CasertaRoberto Sabbatini

Published in: PloS one (2018)

The final results suggest that elderly patients with pretreated metastatic RCC may benefit from therapy with nivolumab.

Keyphrases

metastatic renal cell carcinoma
squamous cell carcinoma
small cell lung cancer
electronic health record
quality improvement
middle aged
renal cell carcinoma
big data
community dwelling
machine learning
data analysis
artificial intelligence
bone marrow
deep learning
smoking cessation
replacement therapy